BG100192A - 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents - Google Patents
2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agentsInfo
- Publication number
- BG100192A BG100192A BG100192A BG10019295A BG100192A BG 100192 A BG100192 A BG 100192A BG 100192 A BG100192 A BG 100192A BG 10019295 A BG10019295 A BG 10019295A BG 100192 A BG100192 A BG 100192A
- Authority
- BG
- Bulgaria
- Prior art keywords
- complexes
- pyridylmethylenepolyazamacrocyclophosphonic
- derivatives
- acids
- contrast agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/281—Means for the use of in vitro contrast agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/057,588 US5462725A (en) | 1993-05-06 | 1993-05-06 | 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| PCT/US1994/005009 WO1994026275A1 (en) | 1993-05-06 | 1994-05-05 | 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG100192A true BG100192A (en) | 1996-12-31 |
Family
ID=22011534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG100192A BG100192A (en) | 1993-05-06 | 1995-12-05 | 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5462725A (de) |
| EP (1) | EP0711300B1 (de) |
| JP (1) | JPH08510245A (de) |
| CN (1) | CN1125905A (de) |
| AT (1) | ATE227297T1 (de) |
| AU (1) | AU678583B2 (de) |
| BG (1) | BG100192A (de) |
| CA (1) | CA2162174A1 (de) |
| CZ (1) | CZ289595A3 (de) |
| DE (1) | DE69431660T2 (de) |
| FI (1) | FI955319A7 (de) |
| HU (1) | HUT74565A (de) |
| LV (1) | LV11430B (de) |
| NO (1) | NO301829B1 (de) |
| PL (1) | PL311643A1 (de) |
| SG (1) | SG46458A1 (de) |
| WO (1) | WO1994026275A1 (de) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5409689A (en) * | 1993-08-13 | 1995-04-25 | Concat, Ltd. | MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms |
| DE19523891C1 (de) * | 1995-06-30 | 1996-11-21 | Hoechst Ag | Chirale Mangan-triazanonankomplexe und Verfahren zu ihrer Herstellung |
| ATE254129T1 (de) * | 1996-04-19 | 2003-11-15 | Dow Global Technologies Inc | Fluoreszierende chelate als gewebespezifische bildgebende mittel |
| US7632651B2 (en) | 1997-09-15 | 2009-12-15 | Mds Analytical Technologies (Us) Inc. | Molecular modification assays |
| US6685914B1 (en) | 1999-09-13 | 2004-02-03 | Bristol-Myers Squibb Pharma Company | Macrocyclic chelants for metallopharmaceuticals |
| EP1362861B1 (de) * | 1999-09-13 | 2005-12-14 | Bristol-Myers Squibb Pharma Company | Makrocyclische Chelatbildner für Metallopharmazeutika |
| ES2211602T3 (es) * | 1999-09-13 | 2004-07-16 | Bristol-Myers Squibb Pharma Company | Quelantes macrociclicos para productos metalofarmaceuticos. |
| WO2003020701A2 (en) * | 2001-09-04 | 2003-03-13 | Texas Tech University | Multi-use multimodal imaging chelates |
| WO2003035655A1 (en) * | 2001-10-22 | 2003-05-01 | Texas Tech University | Tissue specific fluorescent chelates |
| AU2003234576A1 (en) * | 2002-05-17 | 2003-12-02 | Case Western Reserve University | Chemical shift markers for improved wireless fiducial marker tracking |
| US20060210479A1 (en) * | 2004-08-10 | 2006-09-21 | Dow Global Technologies Inc. | Targeting chelants and chelates |
| EP1637524A1 (de) * | 2004-09-20 | 2006-03-22 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | 10-substituierte 1-, 4, 7,-tris (carboxymethyl)-1,4,7,10-tetraazacyclo-dodecanederivate zur Verwendung als Kontrastmittel |
| TR201808537T4 (tr) | 2004-09-23 | 2018-07-23 | Genentech Inc | Sistein değiştirilmiş antikorlar ve konjugatlar. |
| US20100111856A1 (en) | 2004-09-23 | 2010-05-06 | Herman Gill | Zirconium-radiolabeled, cysteine engineered antibody conjugates |
| WO2006039505A2 (en) * | 2004-09-30 | 2006-04-13 | Molecular Devices Corporation | Luminescent lanthanide complexes |
| PT2032606E (pt) | 2006-05-30 | 2014-02-05 | Genentech Inc | Anticorpos e imunoconjugados e respetivas utilizações |
| PT2845866T (pt) | 2006-10-27 | 2017-08-09 | Genentech Inc | Anticorpos e imunoconjugados e utilizações dos mesmos |
| US7834154B2 (en) | 2007-02-09 | 2010-11-16 | Genentech, Inc. | Anti-ROBO4 antibodies and uses therefor |
| PT2474557E (pt) | 2007-07-16 | 2014-12-03 | Genentech Inc | Anticorpos e imunoconjugados anti-cd79b e métodos de utilização |
| PE20140625A1 (es) | 2007-07-16 | 2014-05-29 | Genentech Inc | ANTICUERPOS ANTI-CD79b E INMUNOCONJUGADOS HUMANIZADOS |
| DK2657253T3 (en) | 2008-01-31 | 2017-10-09 | Genentech Inc | Anti-CD79b antibodies and immune conjugates and methods of use |
| US8499251B2 (en) | 2009-01-07 | 2013-07-30 | Microsoft Corporation | Virtual page turn |
| MA33256B1 (fr) | 2009-04-01 | 2012-05-02 | Genentech Inc | Anticorps et immunoconjugués anti-fcrh5 et procédés d'utilisation |
| EP2437785B1 (de) | 2009-06-04 | 2015-02-25 | Novartis AG | Verfahren zur identifizierung von stellen für igg-konjugation |
| CA2781682A1 (en) | 2009-12-04 | 2011-06-09 | Genentech, Inc. | Multispecific antibodies, antibody analogs, compositions, and methods |
| NZ701208A (en) | 2010-06-03 | 2016-05-27 | Genentech Inc | Immuno-pet imaging of antibodies and immunoconjugates and uses thereof |
| CA3220104A1 (en) | 2010-06-08 | 2011-12-15 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| MX354303B (es) | 2012-07-04 | 2018-02-23 | Hoffmann La Roche | Anticuerpos de anti-biotina y metodos de uso. |
| EP2869837B1 (de) | 2012-07-04 | 2016-09-14 | F. Hoffmann-La Roche AG | Anti-theophyllin-antikörper und verwendungsverfahren |
| SG11201407420RA (en) | 2012-07-04 | 2015-02-27 | Hoffmann La Roche | Covalently linked antigen-antibody conjugates |
| BR112016014945A2 (pt) | 2014-01-03 | 2018-01-23 | F. Hoffmann-La Roche Ag | conjugado, formulação farmacêutica e uso |
| WO2015101586A1 (en) | 2014-01-03 | 2015-07-09 | F. Hoffmann-La Roche Ag | Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles |
| EP3089758B1 (de) | 2014-01-03 | 2021-01-27 | F.Hoffmann-La Roche Ag | Kovalent verknüpfte helikar-/anti-helikar-antikörperkonjugate und verwendungen davon |
| JP2017531620A (ja) | 2014-09-12 | 2017-10-26 | ジェネンテック， インコーポレイテッド | システイン操作抗体及びコンジュゲート |
| MX381723B (es) | 2014-12-17 | 2025-03-13 | Hoffmann La Roche | Metodos novedosos para conjugacion de polipeptido mediada por enzimas usando sortasa. |
| EP3353310B1 (de) | 2015-09-25 | 2020-04-29 | H. Hoffnabb-La Roche Ag | Verfahren zur herstellung von thioestern unter verwendung einer sortase a |
| EP3353201B1 (de) | 2015-09-25 | 2021-09-08 | F. Hoffmann-La Roche AG | Rekombinante schwere immunglobulinketten mit einer sortasekonjugationsschleife und konjugate davon |
| CN108138158B (zh) | 2015-09-25 | 2021-11-09 | 豪夫迈·罗氏有限公司 | 可溶性分选酶a |
| JP6998863B2 (ja) | 2015-09-25 | 2022-02-04 | エフ．ホフマン－ラ ロシュ アーゲー | 深共融溶媒におけるソルターゼａを利用したアミド基転移 |
| CN109072212B (zh) | 2016-03-30 | 2022-10-04 | 豪夫迈·罗氏有限公司 | 改善的分选酶 |
| EP3609897A1 (de) | 2017-04-12 | 2020-02-19 | H. Hoffnabb-La Roche Ag | Verfahren zur markierung von aldehydhaltigen zielmolekülen |
| ES3065893T3 (en) | 2017-07-13 | 2026-05-08 | Hoffmann La Roche | New binding agent and assay for pivka |
| KR20200067193A (ko) | 2017-10-20 | 2020-06-11 | 에프. 호프만-라 로슈 아게 | 항체에 대한 카피 보호 |
| JP7402158B2 (ja) | 2017-11-30 | 2023-12-20 | ジェネンテック， インコーポレイテッド | 抗ｐｄ－ｌ１抗体及びｐｄ－ｌ１を検出するためにそれを使用する方法 |
| EP3492460A1 (de) * | 2017-12-01 | 2019-06-05 | Ustav Organicke Chemie A Biochemie Av Cr, V.v.i. | Verbindungen zur trennung von seltenerdelementen, trennverfahren und verwendung davon |
| CN111971300B (zh) | 2018-03-14 | 2024-10-29 | 豪夫迈·罗氏有限公司 | 新颖的抗-肌钙蛋白t抗体 |
| BR112020018235A2 (pt) | 2018-03-14 | 2020-12-29 | F. Hoffmann-La Roche Ag | Métodos para gerar uma biblioteca de polinucleotídeos, bibliotecas de polinucleotídeos, uso de uma biblioteca, método para gerar uma biblioteca de anticorpos e método de seleção de um anticorpo |
| EP3781600A1 (de) | 2018-04-18 | 2021-02-24 | F. Hoffmann-La Roche AG | Neuartige anti-thymidinkinase-antikörper |
| ES2983797T3 (es) | 2018-08-31 | 2024-10-24 | Hoffmann La Roche | Timidina cinasa (TK-1) en índices pronóstico para LDLBG |
| WO2020069433A1 (en) | 2018-09-28 | 2020-04-02 | Imaginab, Inc. | Cd8 imaging constructs and methods of use thereof |
| EP3747852B1 (de) | 2019-06-05 | 2022-10-26 | Ustav organicke chemie a biochemie AV CR, v.v.i. | Verbindungen zur chromatografischen trennung von seltenerdelementen und s-, p-, d- metallen, verfahren zur trennung und verwendung davon |
| KR20220016210A (ko) | 2019-07-22 | 2022-02-08 | 에프. 호프만-라 로슈 아게 | 자궁내막증의 비-침습적 진단용 혈액 생물표지자로써 s100a9 |
| EP4004551A1 (de) | 2019-07-22 | 2022-06-01 | F. Hoffmann-La Roche AG | Substanz p als blutbiomarker zur nichtinvasiven diagnose von endometriose |
| JP7421631B2 (ja) | 2019-07-22 | 2024-01-24 | エフ． ホフマン－ラ ロシュ アーゲー | 子宮内膜症の非侵襲的診断のための血液バイオマーカーとしてのｓ１００ａ８ |
| JP2022542056A (ja) | 2019-07-22 | 2022-09-29 | エフ．ホフマン－ラ ロシュ アーゲー | 子宮内膜症の非侵襲的診断のための血液バイオマーカーとしてのｓ１００ａ６ |
| JP7315781B2 (ja) | 2019-07-22 | 2023-07-26 | エフ． ホフマン－ラ ロシュ アーゲー | 子宮内膜症の非侵襲的診断のための血液バイオマーカーとしてのｓ１００ａ１２ |
| KR20220042367A (ko) | 2019-08-09 | 2022-04-05 | 에프. 호프만-라 로슈 아게 | 신규한 항-트로포닌t 항체 |
| BR112022009371A2 (pt) | 2019-11-15 | 2022-08-09 | Hoffmann La Roche | Métodos para determinar a quantidade ou concentração de um ou mais analitos antibióticos, tubos de amostragem, usos de um reagente de derivatização nucleofílica e analito antibiótico |
| CN116457660A (zh) | 2020-10-30 | 2023-07-18 | 豪夫迈·罗氏有限公司 | Timp1作为胆管癌的标志物 |
| WO2022090455A1 (en) | 2020-11-02 | 2022-05-05 | F. Hoffmann-La Roche Ag | Sars-cov-2 nucleocapsid antibodies |
| WO2022207628A1 (en) | 2021-03-30 | 2022-10-06 | F. Hoffmann-La Roche Ag | Scf as blood biomarker for the non-invasive diagnosis of endometriosis |
| CN117099001A (zh) | 2021-04-01 | 2023-11-21 | 豪夫迈·罗氏有限公司 | Psp94作为血液生物标志物用于子宫内膜异位症的非侵入性诊断 |
| EP4341700A1 (de) | 2021-05-17 | 2024-03-27 | F. Hoffmann-La Roche AG | Sfrp4 als blutbiomarker zur nichtinvasiven diagnose von adenomyose |
| US20250042976A1 (en) | 2021-10-26 | 2025-02-06 | Roche Diagnostics Operations, Inc. | Monoclonal antibodies specific for sars-cov-2 rbd |
| EP4448564A1 (de) | 2021-12-17 | 2024-10-23 | F. Hoffmann-La Roche AG | Neuer antikörper zum nachweis von amyloid beta 42 (a-beta42) |
| WO2023131594A1 (en) | 2022-01-05 | 2023-07-13 | F. Hoffmann-La Roche Ag | Derivatization of compounds in patient samples for therapeutic drug monitoring (tdm) |
| WO2023247752A1 (en) | 2022-06-23 | 2023-12-28 | F. Hoffmann-La Roche Ag | Method for diagnosing endometriosis and for classifying the stage of endometriosis |
| EP4558826A1 (de) | 2022-07-22 | 2025-05-28 | F. Hoffmann-La Roche AG | Fibroblastenwachstumsfaktor-bindendes protein 1 (fgfbp1) als (blut) biomarker zur diagnose des polyzystischen ovarialsyndroms |
| EP4558825A1 (de) | 2022-07-22 | 2025-05-28 | F. Hoffmann-La Roche AG | Meteorin-ähnliches protein (metrnl) als (blut) biomarker zur diagnose des polyzystischen ovarialsyndroms |
| JP2025524025A (ja) | 2022-07-22 | 2025-07-25 | エフ． ホフマン－ラ ロシュ アーゲー | 多嚢胞性卵巣症候群の診断のための（血液）バイオマーカーとしてのロイコトリエンａ４ヒドロラーゼ（ｌｔａ４ｈ） |
| EP4565570A1 (de) * | 2022-08-01 | 2025-06-11 | Portland State University | Kontraststoffe mit hoher relaxivität und stereoselektives präparat |
| JP2026526931A (ja) | 2023-07-28 | 2026-08-10 | エフ ホフマン－ラ ロッシュ アクチェン ゲゼルシャフト | 子宮内膜症のバイオマーカーとしての血清ＥｐｈＡ１ |
| WO2026120128A1 (en) | 2024-12-05 | 2026-06-11 | Roche Diagnostics Gmbh | Serum transcriptional regulator erg as biomarker for endometriosis |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2609390A (en) * | 1950-06-01 | 1952-09-02 | Frederick C Bersworth | Phosphonic alkylene polyamino acids and method of producing same |
| US3336221A (en) * | 1964-11-05 | 1967-08-15 | Calgon Corp | Method of inhibiting precipitation and scale formation |
| US3331773A (en) * | 1966-07-22 | 1967-07-18 | Grace W R & Co | Process for inhibiting precipitation in water |
| US3434969A (en) * | 1967-08-11 | 1969-03-25 | Calgon Corp | Scale inhibiting |
| US4980148A (en) * | 1985-02-06 | 1990-12-25 | Mallinckrodt, Inc. | Methods for enhancing magnetic resonance imaging |
| US4899755A (en) * | 1985-05-08 | 1990-02-13 | The General Hospital Corporation | Hepatobiliary NMR contrast agents |
| US4880008A (en) * | 1985-05-08 | 1989-11-14 | The General Hospital Corporation | Vivo enhancement of NMR relaxivity |
| EP0353450B1 (de) * | 1988-06-24 | 1995-03-29 | The Dow Chemical Company | Macrocyclische bifunktionelle Chelatbildner, Komplexe davon und ihre konjugierten Antikörper |
| US5247077A (en) * | 1989-06-23 | 1993-09-21 | Celltech Limited | Tri-aza macrocycles and processes for their preparation |
| GB8914543D0 (en) * | 1989-06-23 | 1989-08-09 | Parker David | Chemical compounds |
| FR2672051B1 (fr) * | 1991-01-24 | 1993-05-21 | Guerbet Sa | Nouveaux ligands macrocycliques azotes, procede de preparation, complexes polymetalliques, composition de diagnostic et therapeutique. |
| IL106159A0 (en) * | 1992-06-30 | 1993-10-20 | Dow Chemical Co | Targeted delivery of growth factors for bone regeneration |
| EP0588229A3 (en) * | 1992-09-12 | 1994-06-15 | Hoechst Ag | Macrocyclic chelating agents for the preparation of technetium or rhenium complexes |
-
1993
- 1993-05-06 US US08/057,588 patent/US5462725A/en not_active Expired - Fee Related
-
1994
- 1994-05-05 JP JP6525558A patent/JPH08510245A/ja not_active Ceased
- 1994-05-05 AT AT94917922T patent/ATE227297T1/de not_active IP Right Cessation
- 1994-05-05 HU HU9503174A patent/HUT74565A/hu unknown
- 1994-05-05 SG SG1996004873A patent/SG46458A1/en unknown
- 1994-05-05 PL PL94311643A patent/PL311643A1/xx unknown
- 1994-05-05 DE DE69431660T patent/DE69431660T2/de not_active Expired - Fee Related
- 1994-05-05 EP EP94917922A patent/EP0711300B1/de not_active Expired - Lifetime
- 1994-05-05 CA CA002162174A patent/CA2162174A1/en not_active Abandoned
- 1994-05-05 AU AU69447/94A patent/AU678583B2/en not_active Ceased
- 1994-05-05 WO PCT/US1994/005009 patent/WO1994026275A1/en not_active Ceased
- 1994-05-05 CZ CZ952895A patent/CZ289595A3/cs unknown
- 1994-05-05 FI FI955319A patent/FI955319A7/fi unknown
- 1994-05-05 CN CN94192527.7A patent/CN1125905A/zh active Pending
-
1995
- 1995-11-06 NO NO954440A patent/NO301829B1/no unknown
- 1995-12-05 BG BG100192A patent/BG100192A/xx unknown
- 1995-12-06 LV LVP-95-362A patent/LV11430B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0711300A4 (de) | 1996-03-12 |
| HU9503174D0 (en) | 1996-01-29 |
| NO954440L (no) | 1996-01-05 |
| EP0711300A1 (de) | 1996-05-15 |
| SG46458A1 (en) | 1998-02-20 |
| LV11430B (en) | 1997-04-20 |
| FI955319L (fi) | 1995-12-22 |
| NO954440D0 (no) | 1995-11-06 |
| HUT74565A (en) | 1997-01-28 |
| WO1994026275A1 (en) | 1994-11-24 |
| ATE227297T1 (de) | 2002-11-15 |
| PL311643A1 (en) | 1996-03-04 |
| FI955319A7 (fi) | 1995-12-22 |
| FI955319A0 (fi) | 1995-11-06 |
| JPH08510245A (ja) | 1996-10-29 |
| US5462725A (en) | 1995-10-31 |
| AU6944794A (en) | 1994-12-12 |
| CN1125905A (zh) | 1996-07-03 |
| CZ289595A3 (en) | 1997-01-15 |
| DE69431660D1 (de) | 2002-12-12 |
| EP0711300B1 (de) | 2002-11-06 |
| AU678583B2 (en) | 1997-06-05 |
| CA2162174A1 (en) | 1994-11-24 |
| DE69431660T2 (de) | 2003-08-21 |
| LV11430A (lv) | 1996-08-20 |
| NO301829B1 (no) | 1997-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG100194A (bg) | Трициклополиазамакроциклофосфонови киселини,техни производни и комплекси и използването им като контрастни средства | |
| FI955319A0 (fi) | 2-pyridyylimetyleenipolyatsamakrosyklofosfonihappoja, niiden komplekseja ja johdannaisia käytettäväksi vasta-aineina | |
| AU2054097A (en) | Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents | |
| ATE192047T1 (de) | Bicylclische, polyazamakrocyclocarbonsäure- komplexe, konjugate, herstellung und verwendung als kontraststoffe | |
| ATE160943T1 (de) | Bicycloazamakrocyclophosphon-säure, komplexe, konjugate, kontrastmittel und herstellung | |
| RU93053767A (ru) | Бициклополиазамакроциклофосфоновые кислоты, их комплексы и конъюгаты для применения в качестве контрастных агентов и способы их получения | |
| NO954442L (no) | Bicyklopolyazamakrocyklofosfonsyrer, deres komplekser og konjugater, for anvendelse som kontrastmidler, og fremgangsmåter for deres fremstilling | |
| FI933506L (fi) | Bisyklopolyatsamakrosyklokarboksyylihappokomplekseja, niiden konjugaatteja, menetelmä niiden valmistamiseksi ja käyttö varjoaineina | |
| CA2171728A1 (en) | Triaryl-ethylene derivatives for use in therapy | |
| MY141501A (en) | Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents and processes for their preparation | |
| IT1265251B1 (it) | Derivati iodurati del bifenile e loro impiego diagnostico | |
| MY109649A (en) | Bicyclopol yazamacrocyclocarboxylic acid complexes, and conjugates, processes for their prepration, and use as contrast agents | |
| RU93053897A (ru) | Комплексы бициклополиазамакроциклокарбоновых кислот, их конъюгаты, фармацевтическая композиция, способ диагностики, набор и способ получения |